- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
The Role of Patient Engagement Tools and Patient Advocacy Groups in LEMS Care
A panelist discusses how digital patient engagement tools and collaboration with advocacy groups can enhance treatment adherence and care coordination while providing vital support and resources for individuals managing Lambert-Eaton myasthenic syndrome (LEMS).
EP: 1.LEMS and SCLC: Unraveling the Neuromuscular-Cancer Connection
EP: 2.Strategies to Alleviate the Clinical and Economic Burden of LEMS
EP: 3.The Clinical and Economic Impact of LEMS in SCLC Care
EP: 4.Using Technology for Early Detection of LEMS
EP: 5.Team- and System-Based Approaches to Managing LEMS and Ensuring Access
EP: 6.The Role of Patient Engagement Tools and Patient Advocacy Groups in LEMS Care
Video content above is prompted by the following:
- How can patient engagement tools and technology improve adherence and patient satisfaction in LEMS treatment?
- What role do patient advocacy groups play in supporting care coordination and resource allocation for LEMS patients?
Nomogram Predicts Overall Survival in Patients With Ovarian Cancer, Liver Metastases
January 9th 2025Researchers developed and validated a nomogram to predict 1-, 2-, and 3-year overall survival (OS) in patients with ovarian cancer and liver metastases (OCLM), outperforming an external model in stability and accuracy.
Read More
Real-World Discontinuations of Ocrelizumab in MS Comparable to Pivotal Trials
January 9th 2025Data from a systematic review of 30 real-world studies show comparable discontinuation rates of ocrelizumab to those in pivotal clinical trials among patients with different types of multiple sclerosis (MS).
Read More
